Animalcare Group (LSE:ANCR) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:ANCR Animalcare Group PLC LSE:ANCR
78 GF Score
Price £3.34
GF Value £2.56
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Animalcare Group FFO?

FFO (Funds from operations) only applies to REITs.

LSE:ANCR
78GF Score
Animalcare Group PLC LSE:ANCR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Animalcare Group (LSE:ANCR) Overvalued in 2026?

Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued. The current stock price of £3.34 is trading 30.3% above its estimated GF Value™ of £2.56. GuruFocus considers Animalcare Group to be Modestly Overvalued.

Key valuation signals for LSE:ANCR:

  • FFO:
  • GF Value™: £2.56 vs. price of £3.34 (30.3% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the LSE:ANCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Animalcare Group Business Description

Other Exchanges WQ7:Germany
Address Monks Cross Drive, Moorside, York, GBR, YO32 9LB
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
78GF Score

Get the complete analysis for LSE:ANCR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.34
Price
£2.56
GF Value